More options available for corneal repair

Article

Corneal transplantation is moving away from penetrating keratoplasty toward less invasive endothelial keratoplasty procedures in which only the damaged portion of the cornea is removed and replaced with donor cells.

Key Points

Chehalis, WA-Corneal transplantation is moving away from penetrating keratoplasty (PK) toward less invasive endothelial keratoplasty (EK) procedures in which only the damaged portion of the cornea is removed and replaced with donor cells, according to David Stanfield, OD, FAAO.

While PK is a well-established procedure that generally produces excellent visual results, it has several drawbacks that have spurred surgeons to develop and modify EK techniques, said Dr. Stanfield, Pacific Cataract and Laser Institute, Chehalis, WA.

Following PK, the possibility that the wound will reopen is a concern for at least a year and potentially for the patient's lifetime. Other issues include corneal irregularities and the risk of infection from sutures. A major drawback with conventional PK is that those patients usually develop significant amounts of induced corneal astigmatism, prolonging visual recovery.

EK options

EK was first performed in the 1950s, but was not pursued aggressively until the late 1990s. Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's stripping endothelial keratoplasty (DSEK) are the most commonly performed EK procedures today, Dr. Stanfield said.

"Early EK procedures-including posterior lamellar keratoplasty (PLK) and deep lamellar endothelial keratoplasty (DLEK)-have been refined as surgeons gained experience. The current menu of procedures includes DSAEK, DSEK, and Descemet's membrane endothelial keratoplasty (DMEK). DSEK and DSAEK have a good track record," he said.

Postoperative visual recovery is usually excellent, and with DMEK, a greater percentage of patients have 20/20 visual acuity compared with traditional PK, DSEK, and DSAEK. Visual rehabilitation typically occurs within a few weeks, compared to a year or more with penetrating keratoplasty.

In DSAEK, donor tissue is transferred to an artificial chamber, an automated microkeratome is activated, and donor tissue is trephined. During DSEK procedures, the donor is manually prepared. Steps for preparing the recipient cornea are stripping and removing the Descemet's membrane, folded insertion of the donor through a small, temporal incision, unfolding the tissue with an air bubble, and removal of some of the air.

In patients undergoing DSAEK or DSEK, the donor endothelium is attached to a small layer of stroma. Although the cornea can be remarkably clear postoperatively in these patients, vision may be less than anticipated, probably due to the fact that the extra stromal layer creates a more irregular optical interface.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.